Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-09

Clinical Trial Update: A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for topical azelaic acid 15% in treating mild to moderate perioral dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid 15% (azelaic acid)

Snippet

Sponsor: LEO Pharma | Conditions: Perioral Dermatitis | Phase 2 | Status: COMPLETED